Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis

Br J Anaesth. 2013 Mar;110(3):472-80. doi: 10.1093/bja/aes577. Epub 2013 Feb 4.

Abstract

Background: Sepsis-induced organ failure is the major cause of death in critical care units, and is characterized by a massive dysregulated inflammatory response and oxidative stress. We investigated the effects of treatment with antioxidants that protect mitochondria (MitoQ, MitoE, or melatonin) in a rat model of lipopolysaccharide (LPS) plus peptidoglycan (PepG)-induced acute sepsis, characterized by inflammation, mitochondrial dysfunction and early organ damage.

Methods: Anaesthetized and ventilated rats received an i.v. bolus of LPS and PepG followed by an i.v. infusion of MitoQ, MitoE, melatonin, or saline for 5 h. Organs and blood were then removed for determination of mitochondrial and organ function, oxidative stress, and key cytokines.

Results: MitoQ, MitoE, or melatonin had broadly similar protective effects with improved mitochondrial respiration (P<0.002), reduced oxidative stress (P<0.02), and decreased interleukin-6 levels (P=0.0001). Compared with control rats, antioxidant-treated rats had lower levels of biochemical markers of organ dysfunction, including plasma alanine amino-transferase activity (P=0.02) and creatinine concentrations (P<0.0001).

Conclusions: Antioxidants that act preferentially in mitochondria reduce mitochondrial damage and organ dysfunction and decrease inflammatory responses in a rat model of acute sepsis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Animals
  • Antioxidants / pharmacology*
  • Antioxidants / therapeutic use
  • Biomarkers
  • Cytokines / biosynthesis
  • Escherichia coli
  • Interleukin-6 / metabolism*
  • Kidney Function Tests
  • Lipopolysaccharides
  • Liver Function Tests
  • Male
  • Melatonin / pharmacology
  • Melatonin / therapeutic use
  • Mitochondria / drug effects*
  • Multiple Organ Failure / physiopathology
  • Multiple Organ Failure / prevention & control
  • Organophosphorus Compounds / therapeutic use
  • Oxidative Stress / drug effects*
  • Oxygen Consumption / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Sepsis / chemically induced
  • Sepsis / drug therapy*
  • Sepsis / physiopathology*
  • Staphylococcus aureus
  • Ubiquinone / analogs & derivatives
  • Ubiquinone / therapeutic use

Substances

  • Antioxidants
  • Biomarkers
  • Cytokines
  • Interleukin-6
  • Lipopolysaccharides
  • Organophosphorus Compounds
  • Ubiquinone
  • mitoquinone
  • Melatonin